Bioniche acquires two products from Xanodyne
This article was originally published in Scrip
Executive Summary
Bioniche Pharma has acquired two injectable pain products from Xanodyne Pharmaceuticals – Duraclon (clonidine hydrochloride injection) and methadone hydrochloride injection USP.